Neuropeptides in neuropathic and inflammatory pain with special emphasis on cholecystokinin and galanin.
Neuropeptides present in primary afferents and the dorsal horn of the spinal cord have an important role in the mediation of nociceptive input under normal conditions. Under pathological conditions, such as chronic inflammation or following peripheral nerve injury, the production of peptides and peptide receptors is dramatically altered, leading to a number of functional consequences. In this review, the role of two neuropeptides that undergo such altered expression under pathological conditions, cholecystokinin (CKK) and galanin, is reviewed.
Wiesenfeld-Hallin
Z
Z
Department of Medical Laboratory Sciences and Technology, Section of Clinical Neurophysiology, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. zsuzsanna.wiesenfeldhallin@neurophys.hs.sll.se
Xu
X J
XJ
D000818:Animals; D002766:Cholecystokinin / Q000378:metabolism / Q000502:physiology*; D019004:Galanin / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D020422:Mononeuropathies / Q000378:metabolism*; D009479:Neuropeptides / Q000378:metabolism / Q000502:physiology*; D010146:Pain / Q000378:metabolism*; D011115:Polyneuropathies / Q000378:metabolism*
D009479:Neuropeptides; D019004:Galanin; D002766:Cholecystokinin